Associate Director, Biostatistics

The role

You will be responsible for the delivery, integrity, and quality of clinical data analyses across clinical studies. You will serve as the lead biostatistician for clinical programs and provide technical and business expertise to the clinical development team.

What you will do

• Function as lead biostatistician for a clinical program
• Oversee day-to-day biostatistics activities, timelines, and deliverables for in-house and outsourced services
• Contribute to clinical protocol development, statistical analysis plans, and clinical study reports
• Apply statistical expertise to clinical trial designs, analysis methods, and data displays
• Ensure scientific integrity of statistical methodology applied to clinical studies
• Collaborate with Clinical Operations, Clinical Research & Development, Clinical Pharmacology, Translational Medicine, Clinical Data Management, Pharmacovigilance, Regulatory and Project Management
• Lead and support planning and preparation of regulatory submissions
• Support presentation and publication of clinical trial results
• Help develop department SOPs
• Work with the Head of Biostatistics on project budget, resource planning, re-forecasting, and program milestones

Required qualifications

• 6+ years of experience in the pharmaceutical/biotechnology industry as a statistician
• In-depth knowledge of methodologies applied in clinical trials with focus on registration and life-cycle management
• Strong programming skill using SAS or R
• Working knowledge of CDISC SDTM/ADaM models
• Experience in CRO and vendor oversight
• Highly motivated self-starter
• Creative problem-solver
• Excellent communication
• Strong interpersonal and organizational skills
• High degree of attention to detail
• Ability to interact with cross-functional teams
• Ability to communicate statistical information to non-scientists

Nice to have

• PhD in statistics, biostatistics, or related scientific field
• Oncology experience

About the company

Relay Therapeutics is a clinical-stage precision medicines company transforming the drug discovery process. The company uses a Dynamo platform to integrate experimental and computational approaches to drug protein targets.